Major Shareholder's Potential Stake Reduced to 15.8% as Rights Expire
CELU is trading near its 52-week low of $0.667 (14% above the low) on light trading volume (0.2× avg).
Summary
A major shareholder's potential beneficial ownership in Celularity Inc. has been reduced to 15.8% after rights to acquire additional shares expired, clarifying their current maximum stake.
Key Events · Ownership and Investor Activity · CELU
-
Beneficial Ownership Updated
The Philip & Daniele Barach Family Trust now beneficially owns 5,414,686 shares, representing 15.8% of Celularity Inc.'s Class A Common Stock.
-
Potential Stake Reduced
The trust's right to acquire an additional 2,043,979 shares through convertible notes and warrants expired on June 19, 2026, reducing their maximum potential beneficial ownership from 20.1% to 15.8%.
-
Warrants Became Exercisable
Warrants to purchase 3,707,457 shares at an exercise price of $2.00 per share, issued on December 19, 2025, became exercisable on June 19, 2026.
Analysis · CELU · Life Sciences
This amendment to a Schedule 13D clarifies the beneficial ownership of the Philip & Daniele Barach Family Trust in Celularity Inc. Their potential maximum stake has been reduced from 20.1% to 15.8% because their right to acquire additional convertible notes and warrants expired on June 19, 2026. While the trust remains a significant shareholder, this update indicates they are not increasing their investment beyond the current level, which could be viewed negatively given the company's recent delisting notice.
At the time of this filing, CELU was trading at $0.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $21.9M. The 52-week trading range was $0.67 to $4.35. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.